Repligen

RGEN59

$142.58arrow_drop_up0.61%$0.87

RGEN59

$142.58

arrow_drop_up0.61%$0.87

Performance History

Key Stats
Open	$141.08
Prev. Close	$141.76
EPS	-0.03
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	138.30	145.29
52 Week Range	110.45	211.13

Ratios







EPS	-0.03

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Repligen (RGEN)

Repligen Corp (RGEN) is a leading bioprocessing company that specializes in the development and production of innovative products for the biopharmaceutical industry. With a focus on improving the process of manufacturing biologic drugs, Repligen Corp has established itself as a trusted partner for many biopharmaceutical companies globally. The company's product portfolio includes a range of tools and technologies that are designed to enhance the efficiency, productivity, and quality of bioproduction processes.

One of Repligen Corp's key offerings is its Protein A affinity resins, which are used in the purification of monoclonal antibodies. These resins enable efficient and high-yield capture of antibodies, allowing for cost-effective manufacturing of biotherapeutics. The company also provides a range of other chromatography products, including ion exchange and mixed-mode resins, as well as filtration products such as hollow fiber filters and tangential flow filtration systems.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Anthony J. Hunt
Headquarters: Waltham
Employees: 2025
Exchange: NASDAQ

Keep an eye on Repligen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Repligen's (RGEN) price per share?

The current price per share for Repligen (RGEN) is $142.58. The stock has seen a price change of $0.87 recently, indicating a 0.61% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Repligen (RGEN)?

For Repligen (RGEN), the 52-week high is $211.13, which is 48.08% from the current price. The 52-week low is $110.45, the current price is 29.09% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Repligen (RGEN) a growth stock?

Repligen (RGEN) has shown an average price growth of -3.66% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Repligen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Repligen (RGEN) stock price performance year to date (YTD)?

As of the latest data, Repligen (RGEN) has a year-to-date price change of -20.48%. Over the past month, the stock has experienced a price change of 5.47%. Over the last three months, the change has been -2.78%. Over the past six months, the figure is -9.85%. Looking at a longer horizon, the five-year price change stands at 63.42%.

help

Is Repligen (RGEN) a profitable company?

Repligen (RGEN) has a net income of $41.58M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 44.5% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.22% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $638.76M, although specific revenue growth data is currently not available. The gross profit is $284.25M. Operating income is noted at $54.58M. Furthermore, the EBITDA is $92.14M.

help

What is the market capitalization of Repligen (RGEN)?

Repligen (RGEN) has a market capitalization of $7.99B. The average daily trading volume is 143.18, indicating the stock's liquidity and investor engagement.